Higher level of hexokinase II (HK-II) is shown to be associated with shorter progression free survival (PFS) or overall survival (OS) in the patients with diffuse large B-cell lymphoma (DLBCL) [7]. The gene discussed is HK2; the disease is diffuse large B-cell lymphoma.